China Lung Cancer Diagnostics Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.

    As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.

    This report elaborates on the current development of the Lung Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Qiagen NV

    • bioMérieux

    • Thermo Fisher Scientific

    • Roche Diagnostics

    • Sanofi SA

    • Janssen

    • Agilent Technologies

    • AstraZeneca plc

    By Type:

    • Others

    • Imaging Test

    • Sputum Cytology

    • Biopsy

    • Molecular Test

    By Application:

    • Clinic

    • Hospital

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Lung Cancer Diagnostics Market Overview 2018-2029

    • 1.1 China Lung Cancer Diagnostics Industry Development Overview

    • 1.2 China Lung Cancer Diagnostics Industry Development History

    • 1.3 China Lung Cancer Diagnostics Industry Market Size (2018-2029)

    • 1.4 China Lung Cancer Diagnostics Market Analysis by Type from Production Side

      • 1.4.1 China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Imaging Test (2018-2029)

      • 1.4.3 China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Sputum Cytology (2018-2029)

      • 1.4.4 China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Biopsy (2018-2029)

      • 1.4.5 China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Molecular Test (2018-2029)

    • 1.5 China Lung Cancer Diagnostics Market Analysis by Application from Consumption End

      • 1.5.1 China Lung Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Lung Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Lung Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China Lung Cancer Diagnostics Market Analysis by Region

      • 1.6.1 North China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Lung Cancer Diagnostics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Lung Cancer Diagnostics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Lung Cancer Diagnostics Market Status and Competition Analysis in 2023

      • 2.2.3 China Lung Cancer Diagnostics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Lung Cancer Diagnostics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Lung Cancer Diagnostics Industry Development

    Chapter 3 Lung Cancer DiagnosticsIndustry Chain Analysis

    • 3.1 Lung Cancer Diagnostics Industry Chain

    • 3.2 Lung Cancer Diagnostics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Lung Cancer Diagnostics Market

    • 3.3 Lung Cancer Diagnostics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Lung Cancer Diagnostics Market

    Chapter 4 China Lung Cancer Diagnostics Market, by Type

    • 4.1 China Lung Cancer Diagnostics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Lung Cancer Diagnostics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Lung Cancer Diagnostics Production Volume and Growth Rate, by Type

      • 4.5.1 China Lung Cancer Diagnostics Production Volume and Growth Rate of Others

      • 4.5.2 China Lung Cancer Diagnostics Production Volume and Growth Rate of Imaging Test

      • 4.5.3 China Lung Cancer Diagnostics Production Volume and Growth Rate of Sputum Cytology

      • 4.5.4 China Lung Cancer Diagnostics Production Volume and Growth Rate of Biopsy

      • 4.5.5 China Lung Cancer Diagnostics Production Volume and Growth Rate of Molecular Test

    Chapter 5 China Lung Cancer Diagnostics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Lung Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Lung Cancer Diagnostics Market Size and Growth Rate, by Application

      • 5.5.1 China Lung Cancer Diagnostics Market Size and Growth Rate of Clinic

      • 5.5.2 China Lung Cancer Diagnostics Market Size and Growth Rate of Hospital

      • 5.5.3 China Lung Cancer Diagnostics Market Size and Growth Rate of Other

    Chapter 6 China Lung Cancer Diagnostics Market, by Region

    • 6.1 China Lung Cancer Diagnostics Production Volume and Production Value, by Region

    • 6.2 China Lung Cancer Diagnostics Sales Volume and Sales Value, by Region

    Chapter 7 North China Lung Cancer Diagnostics Market Analysis

    • 7.1 North China Lung Cancer Diagnostics Market, by Type

    • 7.2 North China Lung Cancer Diagnostics Market, by Application

    Chapter 8 Central China Lung Cancer Diagnostics Market Analysis

    • 8.1 Central China Lung Cancer Diagnostics Market, by Type

    • 8.2 Central China Lung Cancer Diagnostics Market, by Application

    Chapter 9 South China Lung Cancer Diagnostics Market Analysis

    • 9.1 South China Lung Cancer Diagnostics Market, by Type

    • 9.2 South China Lung Cancer Diagnostics Market, by Application

    Chapter 10 East China Lung Cancer Diagnostics Market Analysis

    • 10.1 East China Lung Cancer Diagnostics Market, by Type

    • 10.2 East China Lung Cancer Diagnostics Market, by Application

    Chapter 11 Northeast China Lung Cancer Diagnostics Market Analysis

    • 11.1 Northeast China Lung Cancer Diagnostics Market, by Type

    • 11.2 Northeast China Lung Cancer Diagnostics Market, by Application

    Chapter 12 Southwest China Lung Cancer Diagnostics Market Analysis

    • 12.1 Southwest China Lung Cancer Diagnostics Market, by Type

    • 12.2 Southwest China Lung Cancer Diagnostics Market, by Application

    Chapter 13 Northwest China Lung Cancer Diagnostics Market Analysis

    • 13.1 Northwest China Lung Cancer Diagnostics Market, by Type

    • 13.2 Northwest China Lung Cancer Diagnostics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Qiagen NV

        • 14.1.1 Qiagen NV Company Profile

        • 14.1.2 Qiagen NV Lung Cancer Diagnostics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 bioMérieux

        • 14.2.1 bioMérieux Company Profile

        • 14.2.2 bioMérieux Lung Cancer Diagnostics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Thermo Fisher Scientific

        • 14.3.1 Thermo Fisher Scientific Company Profile

        • 14.3.2 Thermo Fisher Scientific Lung Cancer Diagnostics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Roche Diagnostics

        • 14.4.1 Roche Diagnostics Company Profile

        • 14.4.2 Roche Diagnostics Lung Cancer Diagnostics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sanofi SA

        • 14.5.1 Sanofi SA Company Profile

        • 14.5.2 Sanofi SA Lung Cancer Diagnostics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Janssen

        • 14.6.1 Janssen Company Profile

        • 14.6.2 Janssen Lung Cancer Diagnostics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Agilent Technologies

        • 14.7.1 Agilent Technologies Company Profile

        • 14.7.2 Agilent Technologies Lung Cancer Diagnostics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca plc

        • 14.8.1 AstraZeneca plc Company Profile

        • 14.8.2 AstraZeneca plc Lung Cancer Diagnostics Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Lung Cancer Diagnostics Industry Research Conclusions

    • 15.2 Lung Cancer Diagnostics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Lung Cancer Diagnostics Industry Market Size (2018-2029)

    • Figure China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Imaging Test (2018-2029)

    • Figure China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Sputum Cytology (2018-2029)

    • Figure China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Biopsy (2018-2029)

    • Figure China Lung Cancer Diagnostics Production Volume, Production Value and Growth Rate of Molecular Test (2018-2029)

    • Figure China Lung Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Lung Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Lung Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Central China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure South China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure East China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Lung Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Lung Cancer Diagnostics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Lung Cancer Diagnostics Market Share by Type in 2018

    • Figure China Lung Cancer Diagnostics Market Share by Type in 2023

    • Figure China Lung Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Volume and Growth Rate of Imaging Test (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Volume and Growth Rate of Sputum Cytology (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Volume and Growth Rate of Biopsy (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Volume and Growth Rate of Molecular Test (2018-2023)

    • Figure China Lung Cancer Diagnostics Market Share by Application in 2018

    • Figure China Lung Cancer Diagnostics Market Share by Application in 2023

    • Figure China Lung Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • Figure China Lung Cancer Diagnostics Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Lung Cancer Diagnostics Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Lung Cancer Diagnostics Market Size and Growth Rate of Other (2018-2023)

    • Table China Lung Cancer Diagnostics Production Volume by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Production Value by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Figure China Lung Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Sales Volume by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Figure China Lung Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Sales Value by Region (2018-2023)

    • Table China Lung Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Figure China Lung Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Table North China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table North China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure North China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table North China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table North China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure North China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Central China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Central China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Central China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Central China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Central China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Central China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table South China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table South China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure South China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table South China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table South China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure South China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table East China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table East China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure East China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table East China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table East China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure East China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northeast China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northeast China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northeast China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Southwest China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Southwest China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Southwest China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Lung Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northwest China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Lung Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northwest China Lung Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northwest China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Lung Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Qiagen NV Company Profile

    • Table Qiagen NV Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table bioMérieux Company Profile

    • Table bioMérieux Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Roche Diagnostics Company Profile

    • Table Roche Diagnostics Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Janssen Company Profile

    • Table Janssen Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca plc Company Profile

    • Table AstraZeneca plc Lung Cancer Diagnostics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.